A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
Recruiting now · Phase 1/Phase 2
Conditions studied: Lupus Nephritis, Primary Membranous Nephropathy
In brief
This is a Phase 1/2, open-label, multi-center, multi-cohort, non-randomized dose escalation and dose expansion basket study to determine the safety and tolerability of NKX019 (allogeneic CAR NK cells targeting CD19) in participants with autoimmune diseases.
Key facts
- Study ID
- NCT06557265
- Run by
- Nkarta, Inc.
- People needed
- 120
- Starts
- 2024-06-13
- Expected to finish
- 2027-04-01
- Last updated by the study team
- 2026-06-04
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Nkarta Investigational Site — Manati, Puerto Rico (enrolling)
- Nkarta Investigational Site — Tustin, California, United States (enrolling)
- Nkarta Investigational Site — Gainesville, Florida, United States (enrolling)
- Nkarta Investigational Site — Little Rock, Arkansas, United States (enrolling)
- Nkarta Investigational Site — Plantation, Florida, United States (enrolling)
- Nkarta Investigational Site — Tampa, Florida, United States (enrolling)
- Nkarta Investigational Site — Atlanta, Georgia, United States (enrolling)
- Nkarta Investigational Site — Chicago, Illinois, United States (enrolling)
- Nkarta Investigational Site — New Orleans, Louisiana, United States (enrolling)
- Nkarta Investigational Site — Worcester, Massachusetts, United States (enrolling)
- Nkarta Investigational Site — Ann Arbor, Michigan, United States (enrolling)
- Nkarta Investigational Site — Summit, New Jersey, United States (enrolling)
- Nkarta Investigational Site — New York, New York, United States (enrolling)
- Nkarta Investigational Site — Stony Brook, New York, United States (enrolling)
- Nkarta Investigational Site — Syracuse, New York, United States (enrolling)
- Nkarta Investigational Site — Dallas, Texas, United States (enrolling)
- Nkarta Investigational Site — Houston, Texas, United States (enrolling)
- Nkarta Investigational Site — Parkville, Victoria, Australia (enrolling)
- Nkarta Investigational Site — Miami, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.